Back to top
more

Applied DNA Sciences (APDN)

(Delayed Data from NSDQ)

$2.20 USD

2.20
7,530,516

-0.34 (-13.39%)

Updated Aug 26, 2024 04:00 PM ET

After-Market: $2.27 +0.07 (3.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 251)

Industry: Security and Safety Services

Better trading starts here.

Zacks News

Energous (WATT) Reports Q2 Loss, Tops Revenue Estimates

Energous (WATT) delivered earnings and revenue surprises of 12.50% and 22.63%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ADT (ADT) Tops Q2 Earnings and Revenue Estimates

ADT (ADT) delivered earnings and revenue surprises of 20% and 3.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for February 15th

ATGE, ALGN, and APDN have been added to the Zacks Rank #5 (Strong Sell) List on February 15, 2022

Applied DNA Sciences (APDN) Reports Q1 Loss, Lags Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -231.58% and 2.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Napco (NSSC) Lags Q2 Earnings Estimates

Napco (NSSC) delivered earnings and revenue surprises of -66.67% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Applied DNA Sciences (APDN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Johnson Controls (JCI) Surpasses Q1 Earnings and Revenue Estimates

Johnson Controls (JCI) delivered earnings and revenue surprises of 1.89% and 1.64%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -53.13% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Applied DNA Sciences (APDN) Reports Q3 Loss, Lags Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -91.67% and -50.51%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Applied DNA Sciences (APDN) Report Negative Q3 Earnings? What You Should Know

Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for June 29th

ITRG, TARA, QTNT, VNCE and APDN have been added to the Zacks Rank #5 (Strong Sell) List on June 29, 2021.

Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -83.33% and 1.99%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Applied DNA Sciences (APDN) Report Negative Q2 Earnings? What You Should Know

Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Moving Average Crossover Alert: Applied DNA Sciences (APDN)

Applied DNA Sciences (APDN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

Applied DNA Sciences (APDN) Moves 13.2% Higher: Will This Strength Last?

Applied DNA Sciences (APDN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Applied DNA Sciences (APDN) Upgraded to Buy: Here's What You Should Know

Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -12.73% and 15.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Will Applied DNA Sciences (APDN) Report Negative Q1 Earnings? What You Should Know

Applied DNA Sciences (APDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for January 12th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

New Strong Sell Stocks for January 7th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

New Strong Sell Stocks for December 18th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Applied DNA Sciences (APDN) Reports Q4 Loss, Misses Revenue Estimates

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -38.98% and -55.14%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Corporate News for May 15, 2020

Companies In The News Are: APDN, CSCO, IMUX, VRTU